With the addition of FRI, RCA now has a total network of more than 215 physicians across more than 300 locations in the United States. FRI’s retina services include the treatment of retinal detachments, diabetic retinopathy, macular degeneration, laser procedures, macular and vitreous surgery, pediatric retina and complex retinal conditions. Its renowned team of physicians are consistently recognized and selected by their peers as the top doctors, ranking best in the U.S. We are truly honored to work with RCA to bring these amazing benefits to our communities."įor more than 40 years, Florida Retina Institute has proudly delivered excellence in the treatment of vitreo-retinal diseases and surgery throughout Central Florida, North Florida and Southeast Georgia.
"FRI has enjoyed tremendous growth over the past several years, and RCA will elevate our ability to enhance our clinical research programs, invest in our infrastructure allowing for continued growth and improved patients access, ensure early availability of all clinical advancements, and facilitate collaboration amongst an incredible collection of retina specialists. Mavrofrides, M.D., Board-Certified, Fellowship Trained Vitreoretinal Specialist at Florida Retina Institute. "The physicians of Florida Retina Institute are extremely excited about the opportunity to partner with Retina Consultants of America, which we recognize as the largest and most impressive collection of retina specialists in the world," said Elias C.
Murray has held key leadership positions in the International Society of Ocular Oncology (ISOO) including Program Chairman for the International Congress of Ocular Oncology.Florida Retina Institute’s 13 physicians partner with Retina Consultants of America, providing care to approximately 40,000 patients across Central Florida, North Florida and Southeast Georgia. Murray is a a member of the Macula Society, Club Jules Gonin and a Fellow of ARVO and ABO. Murray is the President-Elect of the American Society of Retina Specialists (ASRS) and has served on the Executive Committee of the Retina Society and the International Society of Ocular Oncology. Murray has been recognized with Honor and Senior Honor awards by the American Academy of Ophthalmology (AAO), the Association for Research in Vision and Ophthalmology (ARVO), the Retina Society, the American Society of Retinal Specialists (ASRS), and the International Society of Ocular Oncologists (ISOO). Murray has published over 300 peer reviewed articles and chapters in the field of vitreoretinal surgery and ocular oncology. Murray expanded his health care focus when he graduated with a Master’s in Business Administration (MBA) in 2005. Murray is a graduate of the Johns Hopkins School of Medicine in the combined BA/MD program in 1985, completed his Residency and Chief Residency at the University of California, San Francisco in Ophthalmology and completed both a surgical and research Fellowship in vitreoretinal surgery and ocular oncology at the Eye Institute, Medical College of Wisconsin. Murray’s Ocular Oncology and Retina Center continues to provide International, National and Regional care for patients with life- and sight-threatening complex eye disease.ĭr.
Murray’s focus on founding the private Ocular Oncology and Retina Center was related to his ongoing pursuit of excellence in clinical care particularly targeted on advanced imaging and treatment technologies. Murray continues as Tenured, Professor Emeritus in Ophthalmology and Radiation Oncology with the Bascom Palmer Eye Institute/Sylvester Comprehensive Cancer Center.ĭr. Murray founded the Ocular Oncology and Retina Center in Miami, Florida. Murray’s early academic career was focused on the development of an integrated Ocular Oncology service beginning at the Bascom Palmer Eye Institute, Sylvester Comprehensive Cancer Center. Murray, MD, MBA is currently the Founding Director/CEO of Ocular Oncology and Retina of Miami Florida.
0 kommentar(er)
